11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine

C143H150ClN27O9 — CID 160917839

IUPAC11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine
SMILESCOc1ccc2c3ncc(-c4c(C)ncn4C)cc3n([C@H](c3ccccc3)C3CCOCC3)c2n1.COc1nccc2c3ncc(-c4c(C)cnn4C)cc3n(C(c3ccccc3)C3CCOCC3)c12.Cc1cnn(C)c1-c1cnc2c3ccc(Cl)nc3n([C@H](c3ccccc3)C3CCOCC3)c2c1.Cc1cnn(C)c1-c1cnc2c3ccnc(N4CCOCC4)c3n([C@H](c3ccccc3)C3CCOCC3)c2c1.Cc1cnn(C)c1-c1cnc2c3ccnc(NCCO)c3n(C(c3ccccc3)C3CCOCC3)c2c1
InChIInChI=1S/C31H34N6O2.C29H32N6O2.2C28H29N5O2.C27H26ClN5O/c1-21-19-34-35(2)28(21)24-18-26-27(33-20-24)25-8-11-32-31(36-12-16-39-17-13-36)30(25)37(26)29(22-6-4-3-5-7-22)23-9-14-38-15-10-23;1-19-17-33-34(2)26(19)22-16-24-25(32-18-22)23-8-11-30-29(31-12-13-36)28(23)35(24)27(20-6-4-3-5-7-20)21-9-14-37-15-10-21;1-18-16-31-32(2)25(18)21-15-23-24(30-17-21)22-9-12-29-28(34-3)27(22)33(23)26(19-7-5-4-6-8-19)20-10-13-35-14-11-20;1-18-26(32(2)17-30-18)21-15-23-25(29-16-21)22-9-10-24(34-3)31-28(22)33(23)27(19-7-5-4-6-8-19)20-11-13-35-14-12-20;1-17-15-30-32(2)25(17)20-14-22-24(29-16-20)21-8-9-23(28)31-27(21)33(22)26(18-6-4-3-5-7-18)19-10-12-34-13-11-19/h3-8,11,18-20,23,29H,9-10,12-17H2,1-2H3;3-8,11,16-18,21,27,36H,9-10,12-15H2,1-2H3,(H,30,31);4-9,12,15-17,20,26H,10-11,13-14H2,1-3H3;4-10,15-17,20,27H,11-14H2,1-3H3;3-9,14-16,19,26H,10-13H2,1-2H3/t29-;;;27-;26-/m1..11/s1
InChIKeySRQHFUYGXNFCKN-NGLBBIKBSA-N
MW2426.41 g/mol
LogP26.46
Rot. Bonds26

About 11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine

11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine (PubChem CID 160917839) has the molecular formula C143H150ClN27O9 and a molecular weight of 2426.41 g/mol. Its IUPAC name is 11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine.

Molecular Properties

Compound Name11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine
PubChem CID160917839
Molecular FormulaC143H150ClN27O9
Molecular Weight2426.41 g/mol
Exact Mass2424.18
IUPAC Name11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine
SMILESCOc1ccc2c3ncc(-c4c(C)ncn4C)cc3n([C@H](c3ccccc3)C3CCOCC3)c2n1.COc1nccc2c3ncc(-c4c(C)cnn4C)cc3n(C(c3ccccc3)C3CCOCC3)c12.Cc1cnn(C)c1-c1cnc2c3ccc(Cl)nc3n([C@H](c3ccccc3)C3CCOCC3)c2c1.Cc1cnn(C)c1-c1cnc2c3ccnc(N4CCOCC4)c3n([C@H](c3ccccc3)C3CCOCC3)c2c1.Cc1cnn(C)c1-c1cnc2c3ccnc(NCCO)c3n(C(c3ccccc3)C3CCOCC3)c2c1
InChIInChI=1S/C31H34N6O2.C29H32N6O2.2C28H29N5O2.C27H26ClN5O/c1-21-19-34-35(2)28(21)24-18-26-27(33-20-24)25-8-11-32-31(36-12-16-39-17-13-36)30(25)37(26)29(22-6-4-3-5-7-22)23-9-14-38-15-10-23;1-19-17-33-34(2)26(19)22-16-24-25(32-18-22)23-8-11-30-29(31-12-13-36)28(23)35(24)27(20-6-4-3-5-7-20)21-9-14-37-15-10-21;1-18-16-31-32(2)25(18)21-15-23-24(30-17-21)22-9-12-29-28(34-3)27(22)33(23)26(19-7-5-4-6-8-19)20-10-13-35-14-11-20;1-18-26(32(2)17-30-18)21-15-23-25(29-16-21)22-9-10-24(34-3)31-28(22)33(23)27(19-7-5-4-6-8-19)20-11-13-35-14-12-20;1-17-15-30-32(2)25(17)20-14-22-24(29-16-20)21-8-9-23(28)31-27(21)33(22)26(18-6-4-3-5-7-18)19-10-12-34-13-11-19/h3-8,11,18-20,23,29H,9-10,12-17H2,1-2H3;3-8,11,16-18,21,27,36H,9-10,12-15H2,1-2H3,(H,30,31);4-9,12,15-17,20,26H,10-11,13-14H2,1-3H3;4-10,15-17,20,27H,11-14H2,1-3H3;3-9,14-16,19,26H,10-13H2,1-2H3/t29-;;;27-;26-/m1..11/s1
InChIKeySRQHFUYGXNFCKN-NGLBBIKBSA-N
XLogP26.46
TPSA351.99 Ų
H-Bond Donors2
H-Bond Acceptors36
Rotatable Bonds26
Heavy Atoms180
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002426.41
LogP ≤ 526.46
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1036

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze 11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine?
The IUPAC name of 11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine (CID 160917839) is 11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine.
What is the SMILES notation for 11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine?
The canonical SMILES for 11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine is COc1ccc2c3ncc(-c4c(C)ncn4C)cc3n([C@H](c3ccccc3)C3CCOCC3)c2n1.COc1nccc2c3ncc(-c4c(C)cnn4C)cc3n(C(c3ccccc3)C3CCOCC3)c12.Cc1cnn(C)c1-c1cnc2c3ccc(Cl)nc3n([C@H](c3ccccc3)C3CCOCC3)c2c1.Cc1cnn(C)c1-c1cnc2c3ccnc(N4CCOCC4)c3n([C@H](c3ccccc3)C3CCOCC3)c2c1.Cc1cnn(C)c1-c1cnc2c3ccnc(NCCO)c3n(C(c3ccccc3)C3CCOCC3)c2c1.
What is the InChIKey of 11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine?
The InChIKey is SRQHFUYGXNFCKN-NGLBBIKBSA-N. The full InChI is InChI=1S/C31H34N6O2.C29H32N6O2.2C28H29N5O2.C27H26ClN5O/c1-21-19-34-35(2)28(21)24-18-26-27(33-20-24)25-8-11-32-31(36-12-16-39-17-13-36)30(25)37(26)29(22-6-4-3-5-7-22)23-9-14-38-15-10-23;1-19-17-33-34(2)26(19)22-16-24-25(32-18-22)23-8-11-30-29(31-12-13-36)28(23)35(24)27(20-6-4-3-5-7-20)21-9-14-37-15-10-21;1-18-16-31-32(2)25(18)21-15-23-24(30-17-21)22-9-12-29-28(34-3)27(22)33(23)26(19-7-5-4-6-8-19)20-10-13-35-14-11-20;1-18-26(32(2)17-30-18)21-15-23-25(29-16-21)22-9-10-24(34-3)31-28(22)33(23)27(19-7-5-4-6-8-19)20-11-13-35-14-12-20;1-17-15-30-32(2)25(17)20-14-22-24(29-16-20)21-8-9-23(28)31-27(21)33(22)26(18-6-4-3-5-7-18)19-10-12-34-13-11-19/h3-8,11,18-20,23,29H,9-10,12-17H2,1-2H3;3-8,11,16-18,21,27,36H,9-10,12-15H2,1-2H3,(H,30,31);4-9,12,15-17,20,26H,10-11,13-14H2,1-3H3;4-10,15-17,20,27H,11-14H2,1-3H3;3-9,14-16,19,26H,10-13H2,1-2H3/t29-;;;27-;26-/m1..11/s1.
What are the key properties of 11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine?
11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine has a molecular weight of 2426.41 g/mol, XLogP of 26.46, 26 rotatable bonds, 2 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 11-chloro-5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(3,5-dimethylimidazol-4-yl)-11-methoxy-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;5-(1,4-dimethylpyrazol-5-yl)-10-methoxy-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;2-[[5-(1,4-dimethylpyrazol-5-yl)-8-[oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]amino]ethanol;4-[5-(1,4-dimethylpyrazol-5-yl)-8-[(S)-oxan-4-yl(phenyl)methyl]-3,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-10-yl]morpholine is sourced from PubChem (CID 160917839), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).